Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 28.9%, EPS fell 17.3%, free cash flow grew 220.1% and total debt rose 47.7%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
Follow TFX
Teleflex Incorporated (TFX) EV/Sales
As of 16 October 2026, Teleflex Incorporated (TFX) trades at a EV/Sales of 3.6×. Over the past ten years it has ranged from 2.9× (February 2015) to 9.0× (April 2021); the current reading is higher than 13% of that period. That is above the Medical Instruments & Supplies industry median of 2.9× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.9× | (32.53%) |
| FY2024 | 5.7× | (26.50%) |
| FY2023 | 7.8× | 65.73% |
| FY2022 | 4.7× | (21.14%) |
| FY2021 | 6.0× | (28.69%) |
| FY2020 | 8.4× | 14.33% |
| FY2019 | 7.3× | 31.68% |
| FY2018 | 5.6× | (10.82%) |
| FY2017 | 6.2× | 57.92% |
| FY2016 | 3.9× | 15.53% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.6× | (0.36%) |
| Mar 2026 | 3.6× | (7.60%) |
| Dec 2025 | 3.9× | (39.08%) |
| Sep 2025 | 6.3× | (1.47%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVST Envista Holdings Corporation compare | 1.4× |
| BLCO Bausch + Lomb Corporation compare | 2.0× |
| ATR AptarGroup, Inc. compare | 2.3× |
| ICUI ICU Medical, Inc. compare | 2.3× |
| WRBY Warby Parker Inc. compare | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.6× |
| TFX Teleflex Incorporated | 3.6× |
| STVN Stevanato Group S.p.A. compare | 3.9× |
| PLSE Pulse Biosciences, Inc compare | 2,555× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)